Investigating how enhancing mitochondrial function can help clear tau proteins and improve brain function in tauopathies.
Tau clearance and synaptic and cognitive function rescue by activation of mitochondrial clearance in tauopathy model
This study is looking at how a protein called tau affects memory and brain health in Alzheimer's and similar conditions, and it’s testing whether boosting another protein, PINK1, can help clear out the harmful tau and improve thinking and memory for people with these disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10504329 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of tau proteins in Alzheimer's disease and related disorders, particularly how they contribute to mitochondrial dysfunction and cognitive decline. The study aims to explore the potential of enhancing a protein called PINK1, which is crucial for mitochondrial health, to clear toxic tau proteins and restore synaptic function. By using a tauopathy model, researchers will investigate whether boosting PINK1 can lead to improvements in memory and cognitive abilities, providing insights into new therapeutic strategies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related tauopathies.
Not a fit: Patients with tauopathies who are not experiencing cognitive decline or those with other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve cognitive function and quality of life for patients with tauopathies.
How similar studies have performed: Previous research has shown promise in targeting mitochondrial dysfunction in neurodegenerative diseases, suggesting that this approach could yield beneficial results.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Yan, Shirley Shidu — Columbia University Health Sciences
- Study coordinator: Yan, Shirley Shidu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.